Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

New Single Step ELISA Kits Available for Multiple Analytes

By BiotechDaily International staff writers
Posted on 11 Sep 2013
A new line of ELISA kits with a universal simplified protocol is now available for biotech and life science researchers.

The Abcam plc. (Cambridge, United Kingdom) line of SimpleStep ELISA kits currently comprise kits for the detection of more than 35 molecules ranging from interleukins and interferons to tumor markers.

Abcam states that the new single wash, colorimetric sandwich ELISA kits have a greatly simplified protocol when compared to standard multistep ELISAs, providing significant timesaving and ease of use. This is accomplished by employing a labeled capture and detection antibody which, "immunocapture" the specific analyte from the sample solution. This entire complex (capture antibody/protein/detection antibody) is in turn immobilized in the well of the microtiter plate via the immunoaffinity of an anti-tag antibody coated in the microplate well.

The unified operational protocol calls for a single one-hour incubation at room temperature and a single wash step. Furthermore, the new SimpleStep platform requires no specific training or new instrumentation.

James Murray, general manager of Abcam, said, “Abcam is continually in touch with researchers to anticipate the latest research trends and developments, so that we can continue to meet their needs worldwide. We are excited to see how SimpleStep ELISA kits will help to increase the pace of scientific discoveries.”

Related Links:
Abcam plc.



Channels

Drug Discovery

view channel
Image: Star-like glial cells in red surround alpha-beta plaques in the cortex of a mouse with a model of Alzheimer\'s disease (Photo courtesy of Strittmatter laboratory/Yale University).

Experimental Cancer Drug Reverses Symptoms in Mouse Model of Alzheimer's Disease

An experimental, but clinically disappointing drug for treatment of cancer has been found to be extremely effective in reversing the symptoms of Alzheimer's disease (AD) in a mouse model.... Read more

Business

view channel

NanoString and MD Anderson Collaborate on Development of Novel Multi-Omic Expression Profiling Assays for Cancer

The University of Texas MD Anderson Cancer Center (Houston, TX, USA) and NanoString Technologies, Inc. (Seattle, WA, USA) will partner on development of a revolutionary new type of assay—simultaneously profiling gene and protein expression, initially aiming to discover and validate biomarker signatures for immuno-oncology... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.